Skip to main content
ABCT 2024 58th Annual Convention Main banner
Psychology Tools Ad
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded Session
Recorded Session
Ticketed Session
Ticketed Session
Back
Evaluation ViewAttendees 6

Child / Adolescent - Anxiety
Symposia

Symposium 69 - CBT for Pediatric OCD and Anxiety: Extending Treatment's Effectiveness and Reach

Saturday, November 16, 2024
8:30 AM – 10:00 AM EST
Location: Regency Ballroom C2, Second Floor Mezzanine, Loews Hotel
CE: 1.5

Keywords: Exposure, CBT, Dissemination
Level of Familiarity: Basic to moderate
Recommended Readings: Franklin, M. E., Engelmann, J. M., Bulkes, N. Z., Horvath, G., Piacsek, K., Osterlund, E., Freeman, J. B., Schwartz, R.A., Himle, M., & Riemann, B. C. (2024). Intensive CBT telehealth for pediatric OCD during the COVID-19 pandemic: Comparison with a matched sample treated in person. Journal of the American Academy of Child & Adolescent Psychiatry Open, 2(1): 26-35.,  

Kemp, J., Barker, D., Benito, K., Herren, J., & Freeman, J. (2021). Moderators of psychosocial treatment for pediatric obsessive-compulsive disorder: Summary and recommendations for future directions. Journal of Clinical Child and Adolescent Psychology: The Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 50(4), 478–485.

,  

Farrell LJ, Waters AM, Storch EA, et al. (2023). Closing the gap for children with OCD: A staged-care model of cognitive behavioural therapy with exposure and response prevention. Clinical Child & Family Psychology Review, 20230705.

,   ,  

Anxiety disorders and OCD in youth are associated with significant and clinically impairing symptoms that, if left unaddressed, extend their pernicious effects into adulthood. Fortunately, efficacious forms of treatment have been well established, including cognitive-behavioral therapies (CBT), pharmacotherapy with serotonin reuptake inhibitors (SRIs), and their combination. A prevailing problem in the field, however, is limited access to these empirically supported interventions, particularly for families with limited financial resources, those living in rural settings, and for non-Caucasians. Recent innovations in the field have focused on increasing treatment availability for those with limited access at present, and on improving treatment effectiveness by identifying and clinically addressing negative moderators and predictors of outcome when treatment is accessed. The series of talks presented in this symposium address key aspects of these issues afflicting the field. Dr. Farrell will begin with explication of a multi-technology, multi-modality staged-care model of CBT for pediatric OCD that is based on two decades of research elucidating treatment response predictors and focuses specifically on addressing treatment barriers and inequities; the applicability of the model beyond pediatric OCD and beyond Australia will also be discussed. Next, Dr. Franklin will present on extension of care via telehealth for a very large sample of child and adolescent patients who received multimodal treatment at higher levels of care (partial hospitalization, intensive outpatient), and on identification within this sample of treatment predictors and moderators that will help identify which patients with which demographic and clinical characteristics benefit more from interventions delivered in-person care rather than via telehealth. Dr. Freeman then will describe the rationale, development, and methods for a teams-based approach to the treatment of pediatric OCD and anxiety developed with substantial stakeholder involvement and which addresses quality and workforce issues inherent in treating these conditions in community settings. She will also present baseline data from a large comparison of this teams-based approach to office-based CBT in youth ages 5 – 18 inclusive. Our discussant, Dr. John Piacentini, will then provide his perspective on the talks and on their clinical and research implications going forward. Ample time will be provided for questions and discussions after each of the talks, after which the floor will be opened to audience members to discuss theoretical and clinical issues.    

Learning Objectives:

At the end of this session, the learner will be able to:
  1. Identify the key steps in a staged-care model for pediatric OCD treatment that takes clinical, demographic, and financial factors into account.
  2. Recount the core elements of a "Teams-Based Approach" to exposure treatments for pediatric OCD and anxiety in a variety of clinical settings.
  3. Summarize findings from a large trial that supports the effectiveness of telehealth for pediatric OCD and identifies predictors of outcome
  4. Recognize barriers to care that limit current availability of exposure-based interventions for pediatric OCD and anxiety patients
  5. Explicate next-stage clinical and research initiatives that seek to overcome treatment barriers both nationally and internationally.

Presentations:

  • 8:30 AM – 10:00 AM EST
    (SYM 69) Multimodal Treatment for Pediatric Delivered via Telehealth vs. in Person: predictors, Moderators, and Medication Effects

    Speaker: Martin E. Franklin, Ph.D. (he/him/his) – Rogers Memorial Hospital

    Co-author: Jeffrey Englemann, PhD (he/him/his) – Rogers Behavioral Health

    Co-author: Rachel Schwartz, PhD (she/her/hers) – Rogers Behavioral Health

    Co-author: Hana F. Zickgraf, Ph.D. – Rogers Behavioral Health

    Co-author: Jennifer Freeman, Ph.D. (she/her/hers) – Alpert Medical School of Brown University

    Co-author: Stephanie Eken, MD (she/her/hers) – Rogers Behavioral Health

    Co-author: Michael Himle, PhD (he/him/his) – University of Utah

  • 8:30 AM – 10:00 AM EST
    (SYM 69) Staged-care CBT-ERP for Paediatric OCD: improving Access and Optimising Outcomes for Young People

    Speaker: Lara Farrell, Ph.D. (she/her/hers) – Griffith University

    Co-author: A Waters, PhD (she/her/hers) – Griffith University

    Co-author: Eric Storch, Ph.D. – Baylor College of Medicine

    Co-author: G Simcock, PhD (she/her/hers) – Griffith University

    Co-author: E Perkes, MD (he/him/his) – University of New South Wales

    Co-author: Jessica Grisham, BA, PhD – UNSW Sydney

    Co-author: Katelyn Dyason, PhD (she/her/hers) – University of New South Wales

    Co-author: Thomas H. Ollendick, Ph.D. (he/him/his) – Virginia Tech

  • 8:30 AM – 10:00 AM EST
    (SYM 69) A Team-based Patient-centered Model for Delivering Outpatient Exposure Treatment for Pediatric Anxiety and OCD

    Speaker: Jennifer Freeman, Ph.D. (she/her/hers) – Alpert Medical School of Brown University

    Co-author: Joshua Kemp, PhD (he/him/his) – Alpert Medical School of Brown University; Pediatric Anxiety Research Center

    Co-author: Erin O'Connor, Ph.D. – Bradley Hospital

    Co-author: Jennifer Herren, PhD (she/her/hers) – Alpert Medical School of Brown University/Pediatric anxiety Research Center

    Co-author: Christopher Georgiadis, PhD (he/him/his) – Alpert medical School of Brown University/Pediatric Anxiety Research Center

    Co-author: Giulia Righi, Ph.D. – Alpert Medical School of Brown University

    Co-author: Kristen G. Benito, Ph.D. – Alpert Medical School of Brown University